Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy

about

Development, Characterization, and Evaluation of PSMA-Targeted Glycol Chitosan Micelles for Prostate Cancer Therapy

Item

http://www.wikidata.org/entity/Q59060302

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2014

@uk

name

Development, Characterization, ...... es for Prostate Cancer Therapy

@en

Development, Characterization, ...... es for Prostate Cancer Therapy

@nl

type

Item

label

Development, Characterization, ...... es for Prostate Cancer Therapy

@en

Development, Characterization, ...... es for Prostate Cancer Therapy

@nl

prefLabel

Development, Characterization, ...... es for Prostate Cancer Therapy

@en

Development, Characterization, ...... es for Prostate Cancer Therapy

@nl

P1476

Development, Characterization, ...... es for Prostate Cancer Therapy

@en

P2093

Jianguo Zhao

http://www.w3.org/2001/XMLSchema#string

Jing Xu

http://www.w3.org/2001/XMLSchema#string

Jingmou Yu

http://www.w3.org/2001/XMLSchema#string

Liangliang Wang

http://www.w3.org/2001/XMLSchema#string

Lixin Li

http://www.w3.org/2001/XMLSchema#string

Ming He

http://www.w3.org/2001/XMLSchema#string

Xiao Xu

http://www.w3.org/2001/XMLSchema#string

Yonghua Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2014

Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.

Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.

Identification of a LNCaP-specific binding peptide using phage display.

Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.

Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.

Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen.

TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors.

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/462356

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime